Export-Import Bank Of Korea's MXN1.2 Bil. Global Floating-Rate Bonds Rated 'A' Jan 08

  • ID: 1871059
  • January 2008
  • Region: Global
  • Standard & Poors
1 of 3

SINGAPORE (Standard & Poor's) Jan. 23, 2008Standard & Poor's Ratings Services today said it has assigned its 'A' senior unsecured foreign currency debt rating to the Export-Import Bank of Korea's (Kexim; foreign currency A/Stable/A-1; local currency --/--/A-1) Mexican peso (MXN) 1.2 billion global floating-rate bonds with coupon rate of TIIE (the leading Mexican interbank rate) plus 30 basis points, maturing Jan. 28, 2013. Standard & Poor's issuer credit ratings on Kexim are based on its public policy role as Korea's official export credit agency. Kexim provides financial facilities in support of the Korean government's (foreign currency A/Stable/A-1; local currency A+/Stable/A-1) export-led growth strategy, and foreign trade and investment policies. The bank is owned and controlled by the government. "The ratings...

Companies mentioned in this report are:
- Export-Import Bank of Korea

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Export-Import Bank of Korea

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.